Comparison of Quadratus Lumborum Intramuscular and Transmuscular in Postoperative Pain
NCT ID: NCT05005871
Last Updated: 2021-10-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2021-09-01
2021-10-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
One of the postoperative analgesic modalities for SC is quadratus lumborum block (QLB). This technique has advantages in relieving postoperative pain after C-section because it is considered to be able to relieve visceral pain as well as somatic pain. The transmuscular QLB (QLBT) approach is one of the most frequently used. This technique was found to be effective with regard to the distribution of analgesics to the paravertebral spaces which is the hallmark of QLB. However, this technique was found to be difficult to perform. Difficulties were reported related to the position of the procedure i.e. lateral or sitting position.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Quadratus lumborum intramuscular block
The quadratus lumborum intramuscular block will be performed immediately at the end of the surgery. Administration of 0.4 mL of 0.25% bupivacaine will be carried out under ultrasound guidance and performed by experienced anesthesiologists.
Quadratus lumborum block after C-section surgery as postoperative pain management
To manage postoperative pain, the subjects will be allocated to either QLB or QLTB group to receive the respective intervention.
Quadratus lumborum transmucular block
The quadratus lumborum transmuscular block will be performed immediately at the end of the surgery. Administration of 0.4 mL of 0.25% bupivacaine will be carried out under ultrasound guidance and performed by experienced anesthesiologists.
Quadratus lumborum block after C-section surgery as postoperative pain management
To manage postoperative pain, the subjects will be allocated to either QLB or QLTB group to receive the respective intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quadratus lumborum block after C-section surgery as postoperative pain management
To manage postoperative pain, the subjects will be allocated to either QLB or QLTB group to receive the respective intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18-35 years old.
* ASA preoperative physical status 1-2
Exclusion Criteria
* Anatomic abnormalities of the abdomen
* History of allergy to local anesthesia
* History of hyperalgesia
* History of drug abuse (sedatives, opioids, paracetamol, or other pain relievers)
* Require postoperative intensive care
* Refuse to participate in research.
18 Years
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Udayana University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christopher Ryalino, MD
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sanglah General Hospital
Denpasar, Bali, Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UNUD-CTR-FK150621-001
Identifier Type: -
Identifier Source: org_study_id